Analysis of survivin expression in a spectrum of benign to malignant lesions of the breast

Applied Immunohistochemistry and Molecular Morphology

Volumn 12, Issue 4, 2004, Pages 296-304

  Singh, Meenakshi ^a,b   Bleile, Michelle J ^a   Shroyer, A Laurie ^a   Heinz, David ^a   Jarboe, Elke A ^a   Shroyer, Kenneth R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Benign breast lesions; Breast cancer; Carcinoma in situ; Immunohistochemistry; Inhibitor of apoptosis; Survivin

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; SURVIVIN;

ADULT; APOPTOSIS; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; CANCER INVASION; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; NEEDLE BIOPSY; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 10044230404     PISSN: 15412016     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129039-200412000-00003     Document Type: Article

References (32)

1. Ambrosini G, Adida C, Altieri D. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917-921.
2. LaCasse EC, Baird S, Korneluk RG, et al. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogens. 1998;17:3247-3259.
3. Altieri DC, Marchisio C. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest. 1999;49:1327-1333.
4. Jaattela M. Escaping cell death: survival proteins in cancer. Exp Cell Res. 1999;248:30-43.
5. Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396:580-584.
6. Tamm I, Wana Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95) Bax, caspases and anticancer drugs. Cancer Res. 1998;58:5315-5320.
7. Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998;152:43-49.
8. Lu C, Altieri D, Tanigawa N. Expression of a novel anti-apoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 1998;58:1808-1812.
9. Gianani R, Jarboe EA, Orlicky D, et al. Expression of survivin in normal, hyperplastic and neoplastic colonic mucosa. Hum Pathol. 2001;32:119-125.
10. Kawasaki H, Altieri DC, Lu CD, et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 1998;58:5071-5074.
11. Kawasaki H, Toyoda M, Shinohara H, et al. Expression of survivin correlates with apoptosis, proliferation and angiogenesis during human colorectal tumorigenesis. Cancer. 2001;91:2026-2032.
12. Kato J, Kuwabara Y, Mitani M, et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer. 2001;95:92-95.
13. Lehner R, Lucia MS, Jarboe EA, et al. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol Morphol. 2002;10:134-138.
14. Satoh K, Keneko K, Hirota M, et al. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer. 2001;92:271-278.
15. Monzo M, Rosell R, Felip E, et al. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small cell lung cancers. J Clin Oncol. 1999;17:2100-2104.
16. Frost M, Jarboe EA, Orlicky D, et al. Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia and invasive squamous cell carcinoma. Anat Pathol. 2002;117:738-744.
17. Lehner R, Bobak J, Kim NW, et al. Localization of telomerase HTERT protein and survivin in placenta: correlation with placental development and hydatidiform molar pregnancy. Obstet Gynecol. 2001;97:965-970.
18. Lehner R, Enomoto T, McGregor JA, et al. Correlation of survivin mRNA detection with histologic diagnosis in normal endometrium and endometrial carcinoma. Acta Obstet Gynecol Scand. 2002;81:162-167.
19. Adida C, Haioun C, Gaulard P, et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood. 2000;96:1921-1925.
20. Kamihara S, Yamada Y, Hirakata Y, et al. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukemia: survivin is an important determinant for prognosis. Br J Haematol. 2001;114:63-69.
21. Adida C, Berrebi D, Peuchmaur M, et al. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 1998;351:882-883.
22. Kleinshcmidt-DeMasters BK, Heinz D, McCarthy PJ, et al. Survivin in glioblastomas: protein and messenger RNA expression and comparison with telomerase levels. Arch Pathol Lab Med. 2003;127:826-833.
23. Treib K, Lehner R, Stulnig T, et al. Survivin expression in human osteosarcoma is a marker for survival. Eur J Surg Oncol. 2003;29:379-382.
24. Norman GR, Streiner DL. Biostatistics: The Bare Essentials. St. Louis: Mosby; 1994:176-177.
25. Mahotka C, Wenzel M, Springer E, et al. Survivin ΔE×3 and survivin 2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 1999;59:6097-6102.
26. Mahotka D, Krieg T, Krieg A, et al. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int J Cancer. 2002;100:30-36.
27. Mahotka D, Liebmann J, Wenzel M, et al. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ. 2002;9:1334-1342.
28. Krieg A, Mahotka C, Krieg T, et al. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumor progression. Br J Cancer. 2002;86:737-743.
29. Kennedy SM, O'Driscoll L, Purcell R, et al. Prognostic importance of survivin in breast cancer. Br J Cancer. 2003;88:1077-1083.
30. Tanaka K, Wwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast cancer. Clin Cancer Res. 2000;6:127-134.
31. Izawa, Kobayashi D, Nasu S, et al. Relevance of c-erbB2, PLU-1 and survivin mRNA expression to diagnostic assessment of breast cancer. Anticancer Res. 2002;22:2965-2969.
32. O'Connor DS, Schecnner JS, Adida C, et al. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol. 2000;156:393-398.